FutureHouse previews an AI tool for ‘data-driven’ biology discovery

Spread the love

The Future House, Eric Shmidt-backed non-profit, aimed at creating a “AI scientist” in the next decade, has released a new tool that claims that biology can help support “data-driven discovery”. The new equipment comes just one week after the Future House Has launched the API and platformThe

This tool, known as Finch (mainly in the form of research papers) and a prompt, (eg “What can you tell me about the molecular drivers of cancer matses?”) And run the code before making the results and inspecting the results. A Post series on XSam Rodricks, co-founder and CEO of the Future House, compared it to “first-year grade student”.

“[B]Inger [do all] In a few minutes it is a superpower, “Rodricks wrote.”[Finch] Actually finished finding something really great things […] Internally for our own projects, we have considered it great. “

Future House offers, as Many, Many Startups And Tech Giants, this is Finch and other AI equipment will create automated steps in the scientific process any day.

In an essay at the beginning of this yearOpenAI chief executive officer Sam Altman says “superintendent” AI equipment “can greatly accelerate scientific discoveries and innovations.” Similarly, the CEO of anthropic, which has turned on one this week “AI for Science” programAI could have predicted with courage that AI could Help in creating cure for most cancersThe

Yet there is a lack of evidence. Many researchers do not consider AI to be particularly effective today In guiding the scientific process. Obviously, the Future House has not yet discovered a scientific progress or discover a novel with its AI equipment.

An interesting goal for AI companies, especially in terms of biology, especially drug invention. Priority research Assumption In 2024 the market value was $ 65.88 billion and could reach $ 160.31 billion by 2034.

TechCrunch event

Berkeley, CA
|
June 5


Book now

Although there are some successes, the AI ​​Lab did not provide immediate magical solutions. Several companies that hire AI to discover the drugs and co -drugs BeniverHave been damaged High-profile Clinical trial failure In recent years. Mean Alfafold 3, Is widely changedThe

Finch similarly makes “foolish mistakes”, Rodricks said – that’s why Futurehaus is hiring bioinformatics and dignitaries biologists that help in evaluating its accuracy and reliability and trained while in the closed bit.

People may be interested in Sign up hereThe

Leave a Reply

Your email address will not be published. Required fields are marked *